|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
BEZAFIBRATE POTENTIATES THE ACTION OF THE DRUG
|
BEZAFIBRATE POTENTIATES THE ACTION OF THE DRUG
|
BEZAFIBRATE POTENTIATES THE ACTION OF THE DRUG
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
LIPID LOWERING DRUGS LIKE CLOFIBRATE & OTHERS INCREASE HEPATIC CHOLESTROL SECRETION & ENCOURAGE CHOLESTROL GALL STONE FORMATION AND HENCE MAY COUNTERACT THE EFFECTIVENESS OF URSODIOL
|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
CHOLESTYRAMINE REDUCES ABSORPTION IF GIVEN WITHIN ONE HOUR OF EACH OTHER ORALLY, SO IT SHOULD BE GIVEN EITHER ATLEAST 1 HR BEFORE OR 4-6 HRS AFTER CHOLESTYRAMINE
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
OESTROGENS, ORAL CONTRACEPTIVES, CLOFIBRATES & POSSIBLY OTHER LIPID LOWERING DRUGS INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE COUNTERACT THE EFFECTIVENESS OF URSODIOL & LIKE DRUGS
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
ORAL CONTRACEPTIVES INCREASE HEPATIC CHOLESTEROL SECRETION & ENCOURAGE CHOLESTEROL GALL STONE FORMATION & HENCE MAY COUNTEACT THE EFFECTIVENESS OF URSODIOL
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
CONCURRENT USE WITH BILE ACID BINDING DRUGS INCLUDING ANTACIDS, CHARCOAL & CHOLESTYRAMINE SHOULD BE AVOIDED
|
ALUMINIUM BASED ANTACIDS HAVE BEEN SHOWN TO ABSORB BILE ACIDS
|